Corrigendum: Cell-Based Radiotracer Binding and Uptake Inhibition Assays: A Comparison of In Vitro Methods to Assess the Potency of Drugs That Target Monoamine Transporters

Front Pharmacol. 2022 Mar 16:13:878641. doi: 10.3389/fphar.2022.878641. eCollection 2022.

Marija Ilic^{1

2

3}, Julian Maier¹, Marion Holy¹, Kathrin Jaentsch¹, Matthias E Liechti⁴, Gert Lubec³, Michael H Baumann⁵, Harald H Sitte¹, Dino Luethi^{1

4}

¹ Institute of Pharmacology, Center for Physiology and Pharmacology, Medical University of Vienna, Vienna, Austria.
² Department of Pharmaceutical Chemistry, Faculty of Life Sciences, University of Vienna, Vienna, Austria.
³ Neuroproteomics, Paracelsus Private Medical University, Salzburg, Austria.
⁴ Division of Clinical Pharmacology and Toxicology, Department of Biomedicine, University Hospital Basel and University of Basel, Basel, Switzerland.
⁵ Designer Drug Research Unit, Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, Baltimore, MD, United States.

Abstract

[This corrects the article DOI: 10.3389/fphar.2020.00673.].

Keywords: HEK 293; monoamine; radiotracer; stimulant; synaptosomes; transporter.